Hospital Drug Tests Far More Likely for Minority Teens
By Carole Tanzer Miller HealthDay Reporter
FRIDAY, Oct. 4, 2024 -- Teens from minority groups seeking treatment at pediatric trauma centers are more likely than their white counterparts to be tested for drugs and alcohol.
That's the takeaway from a new study led by researchers at UCLA and Children's Hospital Los Angeles.
"While screening can positively affect patients if it is followed by counseling and treatment, it can also lead to negative consequences," said lead study author Dr. Jordan Rook, a resident in general surgery at UCLA's David Geffen School of Medicine.
His team found that injured teens who are Black, Hispanic or American Indian are more likely to be screened for substance use.
"We believe that existing guidelines on substance use screening may be inadequate to achieve equitable high-quality screening in adolescent trauma care," he said in a UCLA news release. "Stricter guidance and oversight and/or the implementation of universal screening protocols and equitable utilization of support services may be needed."
For the study, researchers looked at data on 85,400 trauma patients between the ages of 12 and 17 who were treated at 121 pediatric trauma centers. Of those, 67% were white, 82% were non-Hispanic, 72% were boys and 51% had private insurance.
In all, a quarter of them were tested for alcohol and 22% were tested for drugs, the study found.
Of note:
-
The odds of alcohol screening were 117% higher for American Indians than white patients, and 75% higher for drugs
-
Black patients were 8% more likely than white patients to be screened for alcohol and 13% more likely to be screened for drugs
-
Hispanic patients had a 20% higher likelihood of alcohol screening and were 12% more likely than white teens to be screened for drugs
-
Girls were 32% more likely than boys to be screened for alcohol and 28% more likely to be screened for drugs
-
Teens insured by Medicaid were 15% and 28% more likely to be screened for alcohol and drugs, respectively, than teens with private insurance
Researchers noted that it's unclear if the benefits of screening outweighed any potential harms. And the data don't indicate if tests led to any interventions or treatment.
In addition, overall screening rates are likely to be higher because interview-based screening was not included in the data.
Researchers next plan to investigate the impact of practices at individual hospitals and the accuracy and effectiveness of screening through interviews rather than biochemical testing.
"These efforts seek to equitably increase substance use screening and support services for all adolescents," Rook said.
The findings were published Oct. 4 in the journal JAMA Network Open.
Sources
- UCLA Health, news release, Oct. 4, 2024
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
FDA Sends Warning Letters to Companies Selling Illegal Opioid Compound
TUESDAY, July 15, 2025 -- The U.S Food and Drug Administration has issued seven warning letters to companies illegally marketing products containing 7-hydroxymitragynine (7-OH)...
Schools Should Be Prepared For These Three Medical Emergencies
THURSDAY, July 3, 2025 — There are three common health emergencies for which all U.S. schools should be prepared, a new study says. Brain-related crises like seizures...
Medicaid, Medicare Don't Adequately Cover Addiction Treatment, Study Says
TUESDAY, July 1, 2025 — Opioid addicts covered by Medicare and Medicaid are less likely to receive the mental health and substance use treatment that they need, a new study...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.